Interleukin-1β in tendon injury enhances reparative gene and protein expression in mesenchymal stem cells

Tendon injury in the horse carries a high morbidity and monetary burden. Despite appropriate therapy, reinjury is estimated to occur in 50–65% of cases. Although intralesional mesenchymal stem cell (MSC) therapy has improved tissue architecture and reinjury rates, the mechanisms by which they promot...

Descripción completa

Detalles Bibliográficos
Autores principales: Koch, Drew W., Berglund, Alix K., Messenger, Kristen M., Gilbertie, Jessica M., Ellis, Ilene M., Schnabel, Lauren V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Veterinary Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410625/
https://www.ncbi.nlm.nih.gov/pubmed/36032300
http://dx.doi.org/10.3389/fvets.2022.963759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410625/
https://www.ncbi.nlm.nih.gov/pubmed/36032300
http://dx.doi.org/10.3389/fvets.2022.963759

Ejemplares similares